Endlyz Therapeutics
PrivateLast Round
Early Stage
VC
May 7, 2026
Total Funding Raised
$18.2M
Company Overview
Endlyz Therapeutics is a biotechnology company developing disease-modifying therapeutics to restore endo-lysosomal function for the treatment of Parkinson's disease and other dementias.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endlyz Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Endlyz Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | May 7, 2026 | ||||
| Seed | Mar 31, 2025 | ||||
| Grant | Mar 31, 2025 |
Endlyz Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Seed |
| Parkinson's UK | Early Stage VC, Seed |
| Oxford Science Enterprises | Early Stage VC |
| AbbVie Ventures | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Oxford Science Enterprises | Seed |
| The Dementia Discovery Fund | Early Stage VC |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2026
Raised $17.25M in early stage venture capital.
Endlyz Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Endlyz Therapeutics's valuation, stock price, and market status.
